Pink Sheet is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Antineoplaston promoter Burzynski indicted by Houston federal grand jury.

Executive Summary

ANTINEOPLASTON PROMOTER INDICTED BY HOUSTON FEDERAL GRAND JURY on 75 counts of mail fraud, contempt and FDA violations, Southern Texas U.S. Attorney Gaynelle Griffin Jones announces Nov. 20. Thirty four counts of the federal indictment charge Houston physician Stanislow Burzynski, MD, with mail fraud, while 40 counts cite Burzynski for introducing an unapproved drug into interstate commerce. The physician has treated more than 2,500 patients with antineoplaston for AIDS, arthritis, cancers, precancerous conditions, lupus, multiple sclerosis and Parkinson's disease, the South Texas U.S. Attorney states.
Advertisement
Advertisement
Advertisement
UsernamePublicRestriction

Register

PS027248

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel